TissGeneSummary for CFHR5 |
Gene summary |
Basic gene information | Gene symbol | CFHR5 |
Gene name | complement factor H-related 5 | |
Synonyms | CFHL5|CFHR5D|FHR-5|FHR5 | |
Cytomap | UCSC genome browser: 1q31.3 | |
Type of gene | protein-coding | |
RefGenes | NM_030787.3, | |
Description | complement factor H-related protein 5factor H-related protein 5 | |
Modification date | 20141222 | |
dbXrefs | MIM : 608593 | |
HGNC : HGNC | ||
Ensembl : ENSG00000134389 | ||
HPRD : 06508 | ||
Vega : OTTHUMG00000036517 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_CFHR5 | |
BioGPS: 81494 | ||
Pathway | NCI Pathway Interaction Database: CFHR5 | |
KEGG: CFHR5 | ||
REACTOME: CFHR5 | ||
Pathway Commons: CFHR5 | ||
Context | iHOP: CFHR5 | |
ligand binding site mutation search in PubMed: CFHR5 | ||
UCL Cancer Institute: CFHR5 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Liver | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | LIHC | |
Reference showing the relevant tissue of CFHR5 | ||
Description by TissGene annotations | TissgsKTS CNV gained TissGeneKTS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for CFHR5 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
LIHC | 8.23419194 | 9.68788394 | -1.453692 | 0.00834 | 0.017983631 |
Top |
TissGene-miRNA for CFHR5 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for CFHR5 |
TissGeneSNV for CFHR5 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.D559N | SKCM | 3 |
p.S112F | SKCM | 3 |
p.R465H | CESC | 2 |
p.E300K | SKCM | 2 |
p.D535N | SKCM | 2 |
p.S67F | SKCM | 2 |
p.S152L | SKCM | 2 |
p.P50S | SKCM | 2 |
p.E73K | SKCM | 2 |
p.R517K | SKCM | 2 |
p.E276K | SKCM | 2 |
p.S128L | UCEC | 2 |
p.W340* | SKCM | 2 |
p.S89F | SKCM | 2 |
p.R465L | LUAD | 1 |
p.W67* | UCEC | 1 |
p.Q213L | GBM | 1 |
p.P401T | LUAD | 1 |
p.V205I | UCEC | 1 |
p.H253R | BLCA | 1 |
p.N494K | SKCM | 1 |
p.F216S | HNSC | 1 |
p.P161L | LGG | 1 |
p.T475A | UCEC | 1 |
p.S198F | SKCM | 1 |
p.P114L | SKCM | 1 |
p.P26S | SKCM | 1 |
p.A438V | LUAD | 1 |
p.S128L | SKCM | 1 |
p.R93H | PRAD | 1 |
p.A580T | BLCA | 1 |
p.S128L | DLBC | 1 |
p.C417F | LUAD | 1 |
p.W521R | LGG | 1 |
p.W497R | LGG | 1 |
p.P377S | SKCM | 1 |
p.S43F | SKCM | 1 |
p.S486L | SKCM | 1 |
p.P464S | SKCM | 1 |
p.S88F | SKCM | 1 |
p.E452K | SKCM | 1 |
p.R548K | CESC | 1 |
p.Y189C | PRAD | 1 |
p.E324K | BLCA | 1 |
p.H351Q | STAD | 1 |
p.V287I | HNSC | 1 |
p.A414V | STAD | 1 |
p.E245K | SKCM | 1 |
p.S159Y | LUAD | 1 |
p.S392* | HNSC | 1 |
p.I127F | SKCM | 1 |
p.N150S | SKCM | 1 |
p.M327I | LUAD | 1 |
p.P263A | ACC | 1 |
p.Q540X | SKCM | 1 |
p.E318D | UCEC | 1 |
p.P246R | GBM | 1 |
p.M538I | SKCM | 1 |
p.R230Q | SKCM | 1 |
p.P493S | SKCM | 1 |
p.G305E | SKCM | 1 |
p.T268A | UCEC | 1 |
p.S208L | SKCM | 1 |
p.R477H | UCEC | 1 |
p.P90L | SKCM | 1 |
p.Q111K | LUAD | 1 |
p.W158* | SKCM | 1 |
p.R555X | COAD | 1 |
p.L144I | LUAD | 1 |
p.R69H | PAAD | 1 |
p.S174F | SKCM | 1 |
p.V263I | HNSC | 1 |
p.R493K | SKCM | 1 |
p.V360G | SKCM | 1 |
p.Q237* | SKCM | 1 |
p.R459Q | SKCM | 1 |
p.P212S | SKCM | 1 |
p.P477L | SKCM | 1 |
p.P199Q | READ | 1 |
p.C592Y | CESC | 1 |
p.T406K | LUAD | 1 |
p.P401L | SKCM | 1 |
p.G141E | SKCM | 1 |
p.M321L | LIHC | 1 |
p.A571V | BLCA | 1 |
p.R579* | SKCM | 1 |
p.R19* | UCEC | 1 |
p.Y303N | LUAD | 1 |
p.A536V | STAD | 1 |
p.Q544R | LUAD | 1 |
p.P590R | LUAD | 1 |
p.N518K | SKCM | 1 |
p.D459H | HNSC | 1 |
p.E73D | ESCA | 1 |
p.E98K | BLCA | 1 |
p.P65S | SKCM | 1 |
p.A414V | LUAD | 1 |
p.N400K | BLCA | 1 |
p.I249M | STAD | 1 |
p.A447S | STAD | 1 |
p.H375Y | SKCM | 1 |
p.F241V | COAD | 1 |
p.G72E | SKCM | 1 |
p.E221K | SKCM | 1 |
p.Q213X | SKCM | 1 |
p.C441S | HNSC | 1 |
p.E428K | SKCM | 1 |
p.C449R | LUSC | 1 |
p.P577T | LUAD | 1 |
p.R380C | ESCA | 1 |
p.W316X | SKCM | 1 |
p.A571E | LUAD | 1 |
p.P62S | SKCM | 1 |
p.V508A | GBM | 1 |
p.N238K | READ | 1 |
p.A547E | LUAD | 1 |
p.E218A | STAD | 1 |
p.D35N | SKCM | 1 |
p.P41S | SKCM | 1 |
p.P81L | STAD | 1 |
p.M345I | SARC | 1 |
p.Q237E | CESC | 1 |
p.N376S | BLCA | 1 |
p.P401S | SKCM | 1 |
p.R356S | LUSC | 1 |
p.D132N | SKCM | 1 |
p.F554L | UCS | 1 |
p.Q544E | LUAD | 1 |
p.S61A | BRCA | 1 |
p.K528Q | UCEC | 1 |
p.S454Y | OV | 1 |
p.R206Q | SKCM | 1 |
p.P174L | SKCM | 1 |
p.S353Y | COAD | 1 |
p.S550* | UCEC | 1 |
p.R69H | PRAD | 1 |
p.C441F | LUAD | 1 |
p.Q509* | SKCM | 1 |
p.F481S | CHOL | 1 |
p.Q135K | LUAD | 1 |
p.P344S | SKCM | 1 |
p.R477C | BRCA | 1 |
p.P239A | ACC | 1 |
p.C275* | LUAD | 1 |
p.G183V | LUSC | 1 |
p.T533A | STAD | 1 |
p.F241L | UCEC | 1 |
p.D483H | HNSC | 1 |
p.P137L | LGG | 1 |
p.N376K | BLCA | 1 |
p.E124D | STAD | 1 |
p.D108N | SKCM | 1 |
p.F505S | CHOL | 1 |
p.G329E | SKCM | 1 |
p.W436* | STAD | 1 |
p.S184L | SKCM | 1 |
p.Q411P | MESO | 1 |
p.K186* | PRAD | 1 |
p.A556E | COAD | 1 |
p.E49K | SKCM | 1 |
p.P62H | LUSC | 1 |
p.Q520R | LUAD | 1 |
p.G245R | READ | 1 |
p.K332N | UCEC | 1 |
p.119_120SL>RI | LUAD | 1 |
p.P105L | STAD | 1 |
p.T484A | LGG | 1 |
p.R548K | SKCM | 1 |
p.S164G | STAD | 1 |
p.P448S | SKCM | 1 |
p.P86S | SKCM | 1 |
p.P273T | LUSC | 1 |
p.S174Y | LUSC | 1 |
p.G294E | CESC | 1 |
p.F578L | UCS | 1 |
p.D59N | SKCM | 1 |
p.P568L | SKCM | 1 |
p.R356C | ESCA | 1 |
p.G278* | THCA | 1 |
p.D38E | STAD | 1 |
p.T382K | LUAD | 1 |
p.P105L | LGG | 1 |
p.P453L | SKCM | 1 |
p.P236S | SKCM | 1 |
p.E49D | ESCA | 1 |
p.S143R | LUAD | 1 |
p.C171S | STAD | 1 |
p.S65F | SKCM | 1 |
p.Y279N | LUAD | 1 |
p.I151F | SKCM | 1 |
p.F32L | COAD | 1 |
Top |
TissGeneCNV for CFHR5 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for CFHR5 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | FusionScan | PRAD | TCGA-KC-A7F3-01A | ZNHIT6-CFHR5 | Out-of-Frame | chr1:86167839 | chr1:196977616 |
Top |
TissGeneNet for CFHR5 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for CFHR5 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for CFHR5 |
TissGeneDrug for CFHR5 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for CFHR5 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0022658 | Kidney Diseases | 15 | BeFree |
umls:C0017658 | Glomerulonephritis | 7 | BeFree,GAD |
umls:C0268731 | Renal glomerular disease | 4 | BeFree |
umls:C0019061 | Hemolytic-Uremic Syndrome | 3 | BeFree,GAD |
umls:C0022661 | Kidney Failure, Chronic | 3 | BeFree |
umls:C0242383 | Age related macular degeneration | 3 | BeFree,GAD |
umls:C0268743 | Membranoproliferative Glomerulonephritis, Type II | 3 | BeFree |
umls:C1561643 | Chronic Kidney Diseases | 3 | BeFree |
umls:C2931788 | Atypical Hemolytic Uremic Syndrome | 3 | BeFree,GAD |
umls:C0024141 | Lupus Erythematosus, Systemic | 2 | BeFree |
umls:C0403447 | Chronic Kidney Insufficiency | 2 | BeFree |
umls:C1305904 | Familial hematuria | 2 | BeFree |
umls:C3714534 | dowling-degos disease | 2 | BeFree |
umls:C0017662 | Glomerulonephritis, Membranoproliferative | 1 | BeFree,LHGDN |
umls:C0024301 | Lymphoma, Follicular | 1 | BeFree |
umls:C0024305 | Lymphoma, Non-Hodgkin | 1 | GAD |
umls:C0026821 | Muscle Cramp | 1 | BeFree |
umls:C0035078 | Kidney Failure | 1 | BeFree |
umls:C0038395 | Streptococcal Infections | 1 | BeFree |
umls:C0272240 | Disorder of complement | 1 | BeFree |
umls:C0403440 | Thin basement membrane disease | 1 | BeFree |
umls:C2316810 | Chronic kidney disease stage 5 | 1 | BeFree |
umls:C2749604 | HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1 | 0 | ORPHANET |
umls:C3553720 | CFHR5 DEFICIENCY | 0 | CLINVAR,ORPHANET |